Proceeding contribution from Kevin Barron (Labour) in the House of Commons on Tuesday, 4 November 2008. It occurred during Ministerial statement on NHS Patients (Access to Medicines).
NHS Patients (Access to Medicines)
I welcome the announcement that the timetable for the NICE evaluation process is going to be speeded up, which the Health Select Committee recommended in our last report. Professor Richards says that tight controls will be needed to avoid a two-tier NHS. Does that mean that NICE will need to be more flexible so that drugs presently not available on the NHS become available?
Secondary information
- Type
- Proceeding contribution
- Reference
- 482 c137
- Session
- 2007-08
- Chamber / Committee
- House of Commons chamber
- Subjects
- Access Finance Fees and charges Drugs Private sector NHS Medical treatments Patients Payments National Institute for Health and Care Excellence Consequences of Additional Private Drugs for NHS Care Review
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2023-12-16 01:23:39 +0000
- URI
- http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_505610
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_505610
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_505610